SUN PHARM FDA Approval NDA 208313

NDA 208313

SUN PHARM

FDA Drug Application

Application #208313

Documents

Label2018-07-17
Letter2018-10-26
Review2019-04-12
Letter2020-01-09
Label2020-01-10

Application Sponsors

NDA 208313SUN PHARM

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004
Prescription005
Prescription006
Prescription007
Prescription008
Prescription009
Prescription010

Application Products

001SOLUTION;INTRAVENOUSEQ 1200MG BASE/120ML (EQ 10MG BASE/ML)1INFUGEMGEMCITABINE HYDROCHLORIDE
002SOLUTION;INTRAVENOUSEQ 1300MG BASE/130ML (EQ 10MG BASE/ML)1INFUGEMGEMCITABINE HYDROCHLORIDE
003SOLUTION;INTRAVENOUSEQ 1400MG BASE/140ML (EQ 10MG BASE/ML)1INFUGEMGEMCITABINE HYDROCHLORIDE
004SOLUTION;INTRAVENOUSEQ 1500MG BASE/150ML (EQ 10MG BASE/ML)1INFUGEMGEMCITABINE HYDROCHLORIDE
005SOLUTION;INTRAVENOUSEQ 1600MG BASE/160ML (EQ 10MG BASE/ML)1INFUGEMGEMCITABINE HYDROCHLORIDE
006SOLUTION;INTRAVENOUSEQ 1700MG BASE/170ML (EQ 10MG BASE/ML)1INFUGEMGEMCITABINE HYDROCHLORIDE
007SOLUTION;INTRAVENOUSEQ 1800MG BASE/180ML (EQ 10MG BASE/ML)1INFUGEMGEMCITABINE HYDROCHLORIDE
008SOLUTION;INTRAVENOUSEQ 1900MG BASE/190ML (EQ 10MG BASE/ML)1INFUGEMGEMCITABINE HYDROCHLORIDE
009SOLUTION;INTRAVENOUSEQ 2000MG BASE/200ML (EQ 10MG BASE/ML)1INFUGEMGEMCITABINE HYDROCHLORIDE
010SOLUTION;INTRAVENOUSEQ 2200MG BASE/220ML (EQ 10MG BASE/ML)1INFUGEMGEMCITABINE HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2018-07-16STANDARD
LABELING; LabelingSUPPL2AP2020-01-08STANDARD

Submissions Property Types

ORIG1Null40
SUPPL2Null7

CDER Filings

SUN PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208313
            [companyName] => SUN PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"INFUGEM","activeIngredients":"GEMCITABINE HYDROCHLORIDE","strength":"EQ 1200MG BASE\/120ML (EQ 10MG BASE\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"INFUGEM","activeIngredients":"GEMCITABINE HYDROCHLORIDE","strength":"EQ 1300MG BASE\/130ML (EQ 10MG BASE\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"INFUGEM","activeIngredients":"GEMCITABINE HYDROCHLORIDE","strength":"EQ 1400MG BASE\/140ML (EQ 10MG BASE\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"INFUGEM","activeIngredients":"GEMCITABINE HYDROCHLORIDE","strength":"EQ 1500MG BASE\/150ML (EQ 10MG BASE\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"INFUGEM","activeIngredients":"GEMCITABINE HYDROCHLORIDE","strength":"EQ 1600MG BASE\/160ML (EQ 10MG BASE\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"INFUGEM","activeIngredients":"GEMCITABINE HYDROCHLORIDE","strength":"EQ 1700MG BASE\/170ML (EQ 10MG BASE\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"INFUGEM","activeIngredients":"GEMCITABINE HYDROCHLORIDE","strength":"EQ 1800MG BASE\/180ML (EQ 10MG BASE\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"INFUGEM","activeIngredients":"GEMCITABINE HYDROCHLORIDE","strength":"EQ 1900MG BASE\/190ML (EQ 10MG BASE\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"INFUGEM","activeIngredients":"GEMCITABINE HYDROCHLORIDE","strength":"EQ 2000MG BASE\/200ML (EQ 10MG BASE\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"INFUGEM","activeIngredients":"GEMCITABINE HYDROCHLORIDE","strength":"EQ 2200MG BASE\/220ML (EQ 10MG BASE\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"01\/08\/2020","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/208313s002lbl.pdf\"}]","notes":""},{"actionDate":"07\/16\/2018","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/208313Orig1s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"07\/16\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/208313Orig1s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/208313Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2018\\\/208313Orig1s000TOC.cfm\"}]","notes":">"}]
            [supplements] => [{"actionDate":"01\/08\/2020","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/208313s002lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/208313Orig1s002ltr.pdf\"}]","notes":">"}]
            [actionDate] => 2020-01-08
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.